| AA | Arachidonic acid |
| ACE | Angiotensin-converting enzyme |
| ADP | Adenosine diphosphate |
| AGEs | Advanced glycation end products |
| Akt | Protein kinase B |
| AMI | Acute myocardial infarction |
| aPTT | Activated partial thromboplastin time |
| apoAI | Apoplipoprotein A-I |
| APS | Antiphospholipid syndrome |
| ASA | Acetylsalicylic acid |
| ASO | Antisense oligonucleotides |
| AT | Antithrombin |
| ATP | Adenosine triphosphate |
| cAMP | Cyclic adenosine monophosphate |
| CAT | Catalase |
| CCL | Chemokine (C-C motif) ligand |
| CD | Cluster of differentiation |
| CDT | Catheter-directed thrombolysis |
| CEP | Centrosome-associated protein |
| CHCL1 | Chemokine induces the infiltration of neutrophils |
| CLEC | C-type lectin-like receptor |
| COX | Cyclooxygenase |
| CT | Computed tomography |
| CX3CL1 | Fractalkine |
| CX3CR1 | CX3C chemokine receptor 1 |
| CXCL | Chemokine CXC ligand-1 |
| CYP | Cytochrome P450 |
| CypA | Cyclophilin A |
| DNA | Deoxyribonucleic acid |
| DVT | Deep vein thrombosis |
| eATP | Extracellular ATP |
| ECE | Endothelin converting enzyme |
| ECs | Endothelial cells |
| ED | Endothelial dysfunction |
| EDCF | Endothelium-derived contracting factor |
| EDGF | Endothelium-derived growth factor |
| EDHF | Endothelium-derived hyperpolarizing factor |
| EGF | Epidermal growth factor |
| EMP | Microparticles of endothelial cells |
| EMT | Epithelial-mesenchymal transition |
| eNOS | Endothelial nitric oxide synthase |
| ERK | Extracellular signal-regulated kinase |
| ETC | Electron transport chain |
| FGF | Fibroblast growth factor |
| GP | Glycoprotein |
| GSK | Glycogen synthase kinase |
| H2O | Water |
| H2O2 | Hydrogen peroxide |
| Hb | Haemoglobin |
| HClO | Hypochlorous acid |
| HIF | Hypoxia inducible factor |
| HNE | 4-hydroxy-2-nonenal |
| HO• | Hydroxyl radical |
| HO2• | Hydroperoxyl radical |
| Hp | Haptoglobin |
| HRE | Hormone response element |
| HsCRP | High-sensitivity C-reactive protein |
| 5HT2A | Serotonin receptor 2A |
| HUVEC | Human umbilical vein endothelial cells |
| Hx | Hemopexin |
| IAV | Influenza A virus |
| ICAM | Intercellular adhesion molecule |
| iCypA | Extracellular cyclophilin A |
| IDUs | Intravenous drug users |
| IFN | Interferon |
| IGF | Insulin-like growth factor |
| IL | Interleukin |
| iNOS | Induced nitric oxide synthase |
| INR | International normalized ratio |
| IVC | Inferior vena cava |
| IκBα | Inhibitor of kappa B |
| JAK-2 | Janus kinase 2 |
| JNK | C-Jun N-terminal kinase |
| LMWH | Low molecular weight heparin |
| LOX | Lipoxygenase |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinases |
| MCP | Monocyte chemoattractant protein |
| metHb | Methaemoglobin |
| MHC | Major histocompatibility complex |
| MIDAS | Metal ion-dependent adhesion site |
| MIP-2 | Macrophage inflammatory protein 2 |
| MKP-1 | Mitogen-activated protein kinases phosphatase 1 |
| MMP | Matrix metalloproteinase |
| MPO | Myeloperoxidase |
| MPV | Mean platelets volume |
| mPTP | Mitochondrial permeability transition pore |
| MRI | Magnetic resonance imaging |
| NAD+ | Nicotinamide-adenine dinucleotide phosphate (oxidised form) |
| NADPH | Nicotinamide-adenine dinucleotide phosphate (reduced form) |
| NAPc2 | Nematode anticoagulant protein c2 |
| NETs | Neutrophil extracellular traps |
| NF-κB | Nuclear factor kappa B |
| NLRP3 | Inflammasome is component of the innate immune system |
| NMMHC IIA | Non-muscle myosin heavy chain IIa |
| NO• | Nitric oxide |
| NOX | NADPH oxidase |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NSCLC | Non-small-cell lung carcinoma |
| O2 | Oxygen |
| 1O2 | Singlet oxygen |
| O2•− | Superoxide anion radical |
| ONOO− | Peroxynitrite |
| ox-L | Oxidised lipids |
| ox-P | Oxidised proteins |
| oxyHb | Oxyhaemoglobin |
| PAF | Platelet activating factor |
| PAI-I | Plasminogen activator inhibitor-1 |
| PAR | Protease-activated receptor |
| PAT | Percutaneous aspiration thrombectomy |
| PCDT | Catheter-directed pharmacomechanical thrombolysis |
| PCI | Percutaneous coronary intervention |
| PD-L1 | Programmed death-ligand 1 |
| PDE3 | Phosphodiesterase type 3 |
| PDGF | Platelet-derived growth factor |
| PDI | Protein disulfide-isomerase |
| PE | Pulmonary embolism |
| PF | Platelet factor |
| PGE | Prostaglandin E |
| PGG | Prostaglandin G |
| PGH | Prostaglandin H |
| PGI | Prostacycline |
| PI3Kβ | Phosphatidylinositol 3 kinase β |
| PKA | Protein kinase A |
| PKC | Protein kinase C |
| PLa | Activated platelets |
| PLA | Phospholipase A |
| PLC | Phospholipase C |
| PLCγ2 | Phospholipase Cγ2 |
| PMN | Polymorphonuclear leukocyte |
| PMQ | Pentamethyl quercetin |
| PNS | Saponins Panax notoginseng |
| PPAR-γ | Peroxisome proliferator-activated receptor γ |
| PSGL-1 | P-selectin glycoprotein ligand-1 |
| PT | Prothrombin time |
| PTS | Polygala fallax Hesml root saponin extract |
| RBCs | Red blood cells |
| RNA | Ribonucleic acid |
| ROS | Reactive oxygen species |
| SBSI | Simultaneous decrease in prostacyclin synthase |
| SLO | Streptolysin O |
| SLS | Streptolysin S |
| SOD | Superoxide dismutase |
| STAT3 | Signal transducer and activator of transcription 3 |
| STEC | Shigatoxigenic Escherichia coli |
| TF | Tissue factor |
| TGF-β | Transforming growth factor beta |
| TLR | Toll-like receptor |
| TNF-α | Tumour necrosis factor alfa |
| t-PA | Tissue plasminogen activator |
| TRAP | Thrombin receptor activator peptide |
| TTP | Thrombocytopenic purpura |
| TXA2 | Tromboxan A2 |
| UFH | Unfractionated heparin |
| UV | Ultraviolet |
| VCAM | Vascular cell adhesion molecule |
| VEGF | Vascular endothelial growth factor |
| VKORC1 | Vitamin K epoxide reductase complex |
| VSMCs | Vascular smooth muscle cells |
| VTE | Venous thromboembolism |
| vWF | Von Willebrand factor |